India likely to receive 97.1 million doses of Covid-19 through Covax

India can obtain 97.1 million doses of Covid-19 vaccines through the World Health Organization (WHO) COVAX facility, as stated in COVAX’s interim distribution forecast, released on February 3. The vaccines will be from the Serum Institute of India in Pune. that India has already purchased for the first phase of vaccination that began in the country from January 16. These doses will be in addition to India’s direct deal with the Serum Institute of India in Pune, as Covax is doing, which will also cover several other countries.

India Fastest Country to Hit 4 Million Covid-19 Vaccine Mark in 18 Days: Government

The number of doses is proportional to the size of the population. According to the document, Pakistan will receive 17.2 million doses, Nigeria 16 million, Indonesia 13.7 million, Bangladesh 12.8 million and Brazil 10.6 million.

Covax was created to counter vaccine nationalism, keeping in mind the plight of lower-income countries that could be left behind in the global vaccine race. It is endorsed by Gavi, Vaccine Alliance, WHO, and the Coalition for Epidemic Preparedness Innovations.

Covax will distribute the Oxford vaccine and the Pfizer-BioNTech vaccine, but India will receive the Oxford vaccine from the facility.

According to its document, it will distribute 240 million doses of the Oxford-AstraZeneca vaccine, licensed by the Serum Institute, 96 million doses of the Astrazeneca-Oxford vaccine, under the advance purchase agreement between Gavi and Astrazenecam and 1.2 million of dose of Pfizer vaccine. This will be the first vaccine distribution under Covax that is expected to begin in late February, according to the WHO emergency use license.